USPTO serial 79437774
ALKALIZATOR
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- PILATO, DARREN ANTHONY
- Law office
- TMO LAW OFFICE 125
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALKALIZATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan E. Spitz
Megan E. Spitz Blank Rome LLPOne Logan Square, 130 North 18th StreetPhiladelphia, PA 19103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Machines and machine tools for treatment of materials and for manufacturing, namely, separating machines, extracting machines, mixing machines, and homogenizing machines, all for chemical and biopharmaceutical processing; machines and machine tools for purification and filtration equipment, namely, filtering machines, filter presses, separators, and centrifuges for use in industrial and laboratory purification and filtration processes; material production and processing machines, namely, machines for the production and processing of engineered cells and other biological material in biopharmaceutical manufacturing; separating machines for chemical processing; extracting machines for chemical processing; processing machines for use in the biopharmaceutical industry, namely, bioreactors for use in manufacturing biopharmaceuticals; processing machines using processing liquids for the treatment of biological material, namely, machines for decanting liquids, machines for washing biological material with processing liquids, and machines for resuspending and mixing biological material in processing liquids; machines for use in the processing of cells, namely, extracting machines for chemical and biopharmaceutical processing; industrial chemical reactors for biopharmaceutical manufacturing; bioreactor for use in manufacturing, purifying and filtering biopharmaceuticals; feed pumps being component parts for biopharmaceutical processing installations; pumps for machines; pumps being machines for the biopharmaceutical industry; machines and machine tools for lysis of cells, namely, homogenizing machines for chemical and biopharmaceutical processing; machines and machine tools for extracting, purifying and filtering cell lysate, namely, filter presses for chemical and biopharmaceutical processing; industrial machines for use in separating and isolating biopharmaceutical material, in particular for separating and isolating biological material in the nature of DNA, RNA, proteins, plasmids, plasmid DNA from cells, namely, machines for separating target materials from mixtures of materials; industrial machines for lysing cells, processing, extracting, purifying, and filtering DNA, plasmids, and proteins, namely, apparatus for integrated cell lysis and downstream purification in biopharmaceutical manufacturing; chemical and biopharmaceutical processing equipment; apparatus for the extraction/lysis, purification and filtration of biological material, namely, integrated extraction, lysis, purification and filtration apparatus for biopharmaceutical manufacturing; installations for chemical processing for manufacturing biopharmaceuticals, namely, bioreactors, mixing machines, homogenizing machines, separating machines, filtering machines, filter presses, centrifuges and pumps, all being machines for biopharmaceutical manufacturing; single use chemical reactor for cell lysis, purification of cell lysate and filtration of cell lysate, namely, single use bioreactors and single use lysis reactors for chemical and biopharmaceutical processing in the biopharmaceutical industry; automated bioreactor for cell lysis/extraction, purification of cell lysate and filtration of cell lysate and processing of biological material, namely, bioreactor lysis reactors for chemical and biopharmaceutical processing in the biopharmaceutical industry; apparatus for lysis of cells, purification of cell lysate and filtration of cell lysate for industrial use in the field of biotechnology, the pharmaceutical industry and chemical industry, namely, in line lysis apparatus and lysis reactor apparatus for chemical and biopharmaceutical processing | ACTIVE | — |
| 009 | Scientific instruments, apparatus and equipment, namely, laboratory equipment in the form of incubators, bioreactors, centrifuges, fermentation chambers, filters, electrophoresis equipment for separating molecules in liquid suspension, spectrometers and spectroscopes; cell lysis apparatus and equipment; purification and extraction apparatus and equipment for purifying cell lysate, namely, laboratory apparatus and instruments for extracting nucleic acids, DNA, RNA, plasmids and proteins, not for medical purposes; filtration apparatus and equipment for filtering cell lysate, namely, laboratory filters; electronic control instruments for use with laboratory apparatus and instruments; electric and electronic control instruments for cell lysis equipment; electric and electronic control instruments for extracting filtering and purifying cell lysate; data processing equipment and computers; downloadable computer software for analyzing, collecting, storing, documenting and visualizing data relating to manufacturing processes for the biopharmaceutical, chemical, food and beverage industries; downloadable computer software for analyzing, collecting, storing, documenting and visualizing data related to setting up scientific experiments and analysis of the results of scientific experiments; computer software, recorded, for the operation, control, remote control, monitoring and connection of commercial and research laboratory apparatus and instruments and industrial machines for cell lysis, extraction of cell lysate and filtration of cell lysate, and for the visualisation, documentation, recording and analysis of the operating data thereof; scientific instrument and apparatus with pumps for bioprocessing liquids; disposable plastic bioreactor for processing of cell cultures; apparatus for processing biological material in the nature of cells, DNA, proteins, plasmids, plasmid DNA, namely, bioreactors for laboratory use, apparatus for cultivating micro-organisms, cells and other biological material, chromatography apparatus for laboratory use and laboratory apparatus and instruments for separating and purifying biological and chemical products, all for scientific and research use; single use apparatus for treatment of biological material, namely, disposable plastic bioreactors for cell culture, disposable plastic bags for holding biological material and related reagents, and laboratory vessels for cultivating and incubating cells and other biological material, all for scientific and research use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 16, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 16, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 11, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 27, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |